Dr Sanjeev Srivastava
Associate Editor: Sanjeev Srivastava
Dr. Sanjeev K Srivastava is an Junior Faculty at the University of South Alabama Mitchell Cancer Institute (USAMCI). Dr. Srivastava received his Ph.D. in Human Genetics in 2007, and completed his post-doctoral trainings at the Semmelweis Medical University, Budapest, Hungary and USAMCI. He was promoted as Instructor at USAMCI in October 2015 as part of the ‘Health Disparities in Cancer Research Program’. Dr. Srivastava is engaged in a number of research programs that encompass the areas of breast cancer, pancreatic cancer, prostate cancer, ovarian cancer and melanomas, to identify novel deregulated genes and dissect their underlying regulatory pathways and functional significance. He has published several peer-reviewed articles, and has been the recipient of an international patent. He is a recipient of two NIH/NCI-Small Business Innovation Research (SBIR) Phase I funding for advancing cancer health disparity research. He is also a co-Principal investigator on a NIH/NCI (R01) grant.